ALGEA THERAPIES REF 658.902S.1

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-02-09 for ALGEA THERAPIES REF 658.902S.1 manufactured by Globus Medical, Inc..

Event Text Entries

[38772834] A (b)(6) male undergoing a minimally invasive approach claudication of l4-l5 and during the use of the jamshidi needle was being used and broke off into multiple pieces. At this point the case was converted to open and fluoro was used to locate all the pieces of the fractured needle.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number5450350
MDR Report Key5450350
Date Received2016-02-09
Date of Report2016-02-09
Date of Event2016-02-02
Date Facility Aware2016-02-02
Report Date2016-02-09
Date Reported to FDA2016-02-09
Date Reported to Mfgr2016-02-09
Date Added to Maude2016-02-22
Event Key0
Report Source CodeUser Facility report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationRISK MANAGER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameALGEA THERAPIES
Generic NameAFFIRM ACCESS PACK, ULTRA, TRAY
Product CodeFSH
Date Received2016-02-09
Model NumberREF 658.902S.1
Lot NumberLN002260
Device Expiration Date2019-03-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeNA
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerGLOBUS MEDICAL, INC.
Manufacturer Address2560 GENERAL ARMISTEAD AVE. VALLEY FORGE BUSINESS CENTER AUDUBON PA 19403 US 19403


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2016-02-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.